visible-on: Access Campaign

Gilead Sciences fails on promise to expand access to lifesaving drug for people living with HIV
Tuberculosis: Activists for first time challenge TB drug patent in India, in bid to prevent J&J from extending monopoly
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
Tuberculosis: Activists for first time challenge TB drug patent in India, in bid to prevent J&J from extending monopoly
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
ASEAN and India urged not to trade away people’s lives in trade agreement
ASEAN and India urged not to trade away people’s lives in trade agreement
People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India
People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India
MSF statement on resumption of EU-India FTA negotiations
MSF statement on resumption of EU-India FTA negotiations
MSF responds to India’s first-ever national anti-tuberculosis drug resistance survey
MSF responds to India’s first-ever national anti-tuberculosis drug resistance survey
MSF: India’s decision to give Pfizer unmerited patent on lifesaving pneumonia vaccine limits access for children globally. Photo: Sandra Smiley/MSF
MSF: India’s decision to give Pfizer unmerited patent on lifesaving pneumonia vaccine limits access for children globally
Indian patent office delivers major blow to affordable pneumonia vaccine hopes
India plays an important role in manufacturing and distributing life-saving medicines and vaccines to millions of people across the world. Photo: Giorgos Moutafis
Doctors Without Borders urges India’s Modi to remain committed to affordable medicines during White House meeting